Mifepristone Access Upheld by SCOTUS
The U.S. Supreme Court unanimously rejected a challenge to the FDA's regulations for the abortion pill mifepristone, ensuring its continued nationwide availability. This pivotal decision found that anti-abortion doctors lacked legal standing to sue, thereby preventing a major restriction on abortion access and maintaining the status quo for medication abortion.